An observational study in Coronary Arterial Disease (CAD) and Erectile Dysfunction, sponsored by Kırıkkale University. Active, not recruiting at 1 site in Turkey. Open to male participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-06-13.
Sponsored by Kırıkkale University · Observational
Participant Information Sheet Dear Participant,
Investigators would like to invite participants to participate in a research study and explain what it involves. Please take a few moments to read the following information carefully. If you have any questions, feel free to ask us at any time.
What is this study about? This study aims to understand how coronary angiography (a heart procedure you've recently had) may affect erectile function over time. Investigators are especially interested in whether the degree of blockage in participants' heart vessels and how well participants were treated during the procedure affect erectile health.
What will participants be asked to do?
If participants agree to take part:
Investigators will ask participants to answer a short questionnaire with five questions about their erectile function. This will happen once while participants recover in the hospital and again 6 months later.
Each question is rated on a simple scale from 0 to 5.
Investigators will also collect some medical information, such as your age, weight, height, blood test results, details about your heart condition, other health problems, and the medications participants are taking.
All information will be kept confidential and used only for scientific purposes. Participants' identities will not be revealed in any part of the study.
Do participants have to take part? No. Participation is completely voluntary. Participants can choose not to take part, and you can also stop at any time without giving a reason. Participants' decisions will not affect their medical care in any way.
Will there be any extra tests or costs? No. This study does not involve extra tests beyond regular medical care, such as blood tests or heart monitoring, and participation is free.
How long will the study last? The study will last approximately one year. Once it's completed, participants are welcome to ask for the results from our institution.
Who is conducting the study?
The study is being conducted by:
Assist Prof Dr. Timucin Sipal (Urology Department)
Assist Prof Dr. Caglar Alp (Cardiology Department)
You can contact them anytime using the phone number we have provided.
What happens next? If participants are happy to participate, please sign the attached consent form.
Sincerely, The Research Team
683 studies on the registry are indexed under Erectile Dysfunction; 117 are open to participants now.
This study's planned enrollment of 100 is below the median of 130 across 115 observational studies indexed under Erectile Dysfunction.
Browse Erectile Dysfunction studies →Kırıkkale University is the lead sponsor of 112 studies on the registry; 25 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Male participants who have a heart attack and undergo percutaneous coronary intervention in our institutions and survive the event.
Exclusion Criteria:
Erectile functioning changes following percutaneous coronary intervention from baseline through 6 months
Participants' answers will decrease or increase from the baseline score of 0 to 25 on the IIEF questionnaires following percutaneous coronary intervention after a heart attack.
Time frame: from February 2025 to September 2025
Plan to share: Yes
Supporting information: Study protocol, Sap, Icf, Csr
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kırıkkale University